In vitro development and analysis of escherichia coli and shigella boydii azithromycin-resistant mutants

Microbial Drug Resistance

Volumn 19, Issue 2, 2013, Pages 88-93

  Gomes, Cláudia ^a   Pons, Maria J ^a   Magallon Tejada, Ariel ^a   Durand, David ^b   Lluque, Angela ^b   Mosquito, Susan ^b   Riveros, Maribel ^b   Mercado, Erik ^b   Prada, Ana ^b   Ochoa, Theresa J ^b,c   Ruiz, Joaquim ^a,d,e  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; SHIGELLA BOYDII;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD, PRESCHOOL; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; DYSENTERY, BACILLARY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; SHIGELLA BOYDII;

ESCHERICHIA COLI; SHIGELLA; SHIGELLA BOYDII;

EID: 84875611548     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2012.0036     Document Type: Article

References (33)

1. Bartoloni, A., L. Pallechi, H. Rodriguez, C. Fernandez, A. Mantella, F. Bartalesi, M. Strohmeyer, C. Kristiansson, E. Gotuzzo, F. Paradisi, and G.M. Rossolini. 2009. Antibiotic resistance in a very remote Amazonas community. Int. J. Antimicrob. Agents 33:125-129.
2. Beceiro, A., S. Maharjan, T. Gaulton, M. Doumith, N. C. Soares, H. Dhanji, M. Warner, M. Doyle, M. Hickey, G. Downie, G. Bou, D.M. Livermore, and N. Woodford. 2011. False extended-spectrum b-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins. J. Antimicrob. Chemother. 66:2006-2010.
3. Chavani, N., S. Tiwari, G. Sarangi, B. Mallick, A. Mohapatra, B.P. Paty, and P. Das. 2009. Role of azithromycin against clinical isolates of family Enterobacteriaceae: a comparison of its minimum inhibitory concentration by three different methods. Indian J. Med. Microbiol. 27:107-110.
4. Chittum, H.S., and W.S. Champney. 1994. Ribosomal protein gene sequence changes in erythromycin-resistant mutants of Escherichia coli. J. Bacteriol. 176:6192-6198.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; Twenty-First informational supplement M100-S21. CLSI, Wayne, PA.
6. Cohen, R., P. Reinert, F. De La Rocque, C. Levy, M. Boucherat, M. Robert, M. Navel, N. Brahimi, D. Deforche, B. Palestro, and E. Bingen. 2002. Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis. Pediatr. Infect. Dis. J. 21:297-303.
7. Condon, C., D. Liveris, C. Squires, I. Schwartz, and C.L. Squires. 1995. rRNA operon multiplicity in Escherichia coli and the physiological implications of rrn inactivation. J. Bacteriol. 177:4152-4156.
8. Dongya, M., X. Wencheng, M. Xiaobo and L. Wang. 2008. Transition mutations in 23S rRNA account for acquired resistance to macrolides in Ureaplasma urealyticum. Microb. Drug Resist. 14:183-186.
9. DuPont, H.L. 2009. Clinical practice. Bacterial diarrhea. N. Engl. J. Med. 361:1560-1569.
10. Evans, M.E., and W.B. Titlow. 1998. Levofloxacin selects fluoroquinolone-resistant methicilin-resistant Staphylococcus aureus less frequently than ciprofloxacin. J. Antimicrob. Chemother. 41:285-288.
11. Farrar, W.E. 1985. Antibiotic resistance in developing countries. J. Infect. Dis. 152:1103-1106.
12. Gil, F., F. Ipinza, J. Fuentes, R. Fumeron, J.M. Villarreal, A. Aspée, G.C. Mora, C.C. Va'squez, and C. Saavedra. 2007. The ompW (porin) gene mediates methyl viologen (paraquat) efflux in Salmonella enterica serovar typhimurium. Res. Microbiol. 158:529-536.
13. Gonzales, C., C. Bada, R. Rojas, G. Bernaola, and C. Chávez. 2011. Gúa de práctica cĺnica sobre el diagnóstico y tratamiento de la diarrea aguda infecciosa en Pediatŕa Perú. Rev. Gastroenterol. Perú. 31:258-277.
14. Gunell, M., P.Kotilainen, J. Jalava, P. Huovinen, A. Siitonen, and A.J. Hakanen. 2010. In vitro activity of azithromycin against nontyphoidal Salmonella enterica. Antimicrob. Agents Chemother. 54:3498-3501.
15. Haanperä, M., P. Huovinen, and J. Jalava. 2005. Detection and quantification of macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene by pyrosequencing. Antimicrob. Agents Chemother. 49:457-460.
16. Howie, R.L., J.P. Folster, A. Bowen, E.J. Barzilay, and J.M. Whichard. 2010. Reduced azithromycin susceptibility in Shigella sonnei, United States. Microb. Drug. Resist.16:245-248.
17. Hu, W.S., P.C. Li, and C.Y. Cheng. 2005. Correlation between ceftriaxone resistance of Salmonella enterica serovar Typhimurium and expression of outer membrane proteins OmpW and Ail/OmpX-like protein, which are regulated by BaeR of a two-component system.Antimicrob Agents Chemother. 49:3955-3958.
18. Kaper, J.B., J.P. Nataro, and H.L. Mobley. 2001. Pathogenic Escherichia coli. Nat. Rev. Microbiol. 2:123-140.
19. Lomovskaya, O., and K.A. Bostian. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem. Pharmacol. 71:910-918.
20. Mandomando, I., D. Jaintilal, M.J. Pons, X. Vallè s, M. Espasa, L. Mensa, B. Sigaúque, S. Sanz, J. Sacarlal, E. Macete, F. Abacassamo, P.L. Alonso, and J. Ruiz. 2009. Antimicrobial susceptibility and mechanisms of resistance in Shigella and Salmonella isolates from children under five years of age with diarrhea in rural Mozambique. Antimicrob. Agents Chemother. 53:2450-2454.
21. Marcusson, L.L., N. Frimodt-Møller, and D. Hughes. 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLOS Pathog. 5:e1000541.
22. Navia, M.M., L. Capitano, J. Ruiz, M. Vargas, H. Urassa, D. Schellemberg, J. Gascon, and J. Vila. 1999. Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J. Clin. Microbiol. 37:3113-3117.
23. Ochoa, T.J., E. Mercado, D. Durand, F.P. Rivera, S. Mosquito, C. Contreras, M. Riveros, A. Lluque, F. Barletta, A. Prada, and J. Ruiz. 2011. Frecuencia y patotipos de Escherichia coli diarroge'nica en nin? os peruanos con y sin diarrea. Rev. Peru. Med. Exp. Salud. Publica. 28:13-20.
24. Ochoa, T.J., J. Ruiz, M. Molina, L.J. Del Valle, M. Vargas, A.I. Gil, L. Ecker, F. Barletta, E. Hall, T.G. Cleary, and C.F. Lanata. 2009. High frequency of antimicrobial drug resistance of diarrheagenic Escherichia coli in infants in Peru. Am. J. Trop. Med. Hyg. 81:296-301.
25. Pallecchi, L., E. Riccobono, S. Sennati, A. Mantella, F. Bartalesi, C. Trigoso, E. Gotuzzo, A. Bartoloni, and G.M. Rossolini. 2010. Characterization of small ColE-like plasmids mediating widespread dissemination of the qnrB19 gene in commensal Enterobacteria. Antimicrob. Agents Chemother. 54:678-682.
26. Retsema, J., A. Girald, W. Schelkly, M. Manousos, M. Anderson, G. Bright, R. Borovoy, L. Brennan, and R. Mason. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob. Agents Chemother. 31:1939-1947.
27. Riccobono, E., L. Pallecchi, A. Mantella, F. Bartalesi, I.C. Zeballos, C. Trigoso, A.L. Villagran, A. Bartoloni and G.M. Rossolini. 2012. Carriage of antibiotic-resistant Escherichia coli among healthy children and home-raised chickens: a household study in a resource-limited setting. Microb. Drug Resist. 18:83-87.
28. Ruiz, J., F. Marco, I. Oliveira, J. Vila and J. Gascón. 2007. Trends in antimicrobial resistance levels among Campylobacter spp. causing traveler's diarrhea. APMIS 115:218-224.
29. Ruiz, J., L. Mensa, M.J. Pons, J. Vila, and J. Gascón. 2008. Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability. J. Antimicrob. Chemother. 61:1016-1019.
30. Tav́o, M., J. Vila, M. Perilli, L. Casanas, L. Maciá, G. Amicosante, and M.T. Jimenez de Anta. 2004. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains. J. Med. Microb. 53:1119-1122.
31. Von Seidlein, L., D.R. Kim, M. Ali, H. Lee, X. Wang, V.D. Thiem, G. Do Canh, W. Chaicumpa, M.D. Agtini, A. Hossain, Z.A. Bhutta, C. Mason, O. Sethabutr, K. Talukder, G.B. Nair, J.L. Deen, K. Kotloff, and J. Clemens. A multicentre study of Shigella diarrhea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 3:e353.
32. Zaman, S., M. Fitzpatrick, L. Lindahl, and J. Zengel. 2007. Novel mutations in ribosomal proteins L4 and L22 that confer erythromycin resistance in Escherichia coli. Mol. Microbiol. 66:1039-1050.
33. Zhu, H., H.P. Wang, Y. Jiang, S.P. Hou, Y.J. Liu, and Q.Z. Liu. 2010. Mutations in 23SrRNA and ribosomal protein L4 account for resistance in Chlamydia trachomatis strains selected in vitro by macrolide passage. Andrologia 42:274-280.